Skip to main content

Digoxin

  • Reference work entry
Textbook of Clinical Pediatrics

Digoxin was first introduced as a drug in the treatment of atrial fibrillation in the early twentieth century. Only subsequently was the value of digitalis for the treatment of congestive heart failure established. The syndrome of digoxin toxicity was originally described in 1785 by Withering.

The therapeutic properties of cardiac glycosides such as digoxin, a product of the foxglove plant, have been known since the days of the ancient Romans who used red squill, derived from the sea onion, as a diuretic in heart medicine. Cardiac glycosides are found in certain flowering plants such as oleander and lily-of-the-valley and are components of some herbal dietary supplements. Digitalis toxicity was also well known in previous centuries, and some have suggested that the toxic visual symptoms of digitalis may have played a role in Van Gogh’s use of swirling greens and yellows.

The public health burden of digoxin toxicity declined dramatically from 1991 to 2004 in the United Kingdom and the...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 999.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bronstein AC, Spyker DA, Cantilena LR Jr et al (2008) 2007 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 25th annual report. Clin Toxicol 46(10):927–1057

    Article  Google Scholar 

  • Haynes K, Heitjan DF, Kanetsky PA et al (2008) Declining public health burden of digoxin toxicity from 1991 to 2004. Clin Pharmacol Ther 84(1):90–94

    Article  PubMed  CAS  Google Scholar 

  • Kelly R, Smith T (1992) Recognition and management of digitalis toxicity. Am J Cardiol 69:108G–118G

    Article  PubMed  CAS  Google Scholar 

  • Ratnapalan S, Griffiths K, Costei AM et al (2003) Digoxin-carvedilol interactions in children. J Pediatr 142:572–574

    Article  PubMed  CAS  Google Scholar 

  • Schreiber D, Robertson S (2009) Digitalis toxicity. Available at http://www.emedicine.com/emerg/topic137.htm. Accessed 19 Nov 2009

  • Woolf A, Wenger T, Smith T et al (1992) The use of digoxin specific Fab fragments for severe digitalis intoxication in children. N Engl J Med 326:1739–1744

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicole Gebran PharmD, BCPS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Gebran, N. (2012). Digoxin. In: Elzouki, A.Y., Harfi, H.A., Nazer, H.M., Stapleton, F.B., Oh, W., Whitley, R.J. (eds) Textbook of Clinical Pediatrics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02202-9_275

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-02202-9_275

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-02201-2

  • Online ISBN: 978-3-642-02202-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics